5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prediction of five-year mortality after COPD diagnosis using primary care records

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Accurate prognosis information after a diagnosis of chronic obstructive pulmonary disease (COPD) would facilitate earlier and better informed decisions about the use of prevention strategies and advanced care plans. We therefore aimed to develop and validate an accurate prognosis model for incident COPD cases using only information present in general practitioner (GP) records at the point of diagnosis. Incident COPD patients between 2004–2012 over the age of 35 were studied using records from 396 general practices in England. We developed a model to predict all-cause five-year mortality at the point of COPD diagnosis, using 47,964 English patients. Our model uses age, gender, smoking status, body mass index, forced expiratory volume in 1-second (FEV1) % predicted and 16 co-morbidities (the same number as the Charlson Co-morbidity Index). The performance of our chosen model was validated in all countries of the UK (N = 48,304). Our model performed well, and performed consistently in validation data. The validation area under the curves in each country varied between 0.783–0.809 and the calibration slopes between 0.911–1.04. Our model performed better in this context than models based on the Charlson Co-morbidity Index or Cambridge Multimorbidity Score. We have developed and validated a model that outperforms general multimorbidity scores at predicting five-year mortality after COPD diagnosis. Our model includes only data routinely collected before COPD diagnosis, allowing it to be readily translated into clinical practice, and has been made available through an online risk calculator ( https://skiddle.shinyapps.io/incidentcopdsurvival/).

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          Mortality in COPD: causes, risk factors, and prevention.

          Chronic obstructive pulmonary disease (COPD) is a leading and increasing cause of death, the extent of which is underestimated as a consequence of underdiagnosis and underreporting on death certificates. Data from large trials, such as the Lung Health Study, Towards a Revolution in COPD Health (TORCH), Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT), European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP), and Inhaled Steroids in Obstructive Lung Disease (ISOLDE), have shown that the causes of death in patients with mild COPD are predominantly cancer and cardiovascular disease, but as COPD severity increases, deaths due to non-malignant respiratory disease are increasingly common. In practice, mortality of patients with COPD can be predicted by a variety of measures including: forced expiratory volume in one second (FEV(1)), the ratio of inspiratory and total lung capacities, exercise capacity, dyspnea scores, and composite indices such as the body-mass index (B), degree of airflow obstruction (O), degree of functional dyspnea (D), and exercise capacity (E) (BODE) index. Smoking cessation improves survival in COPD patients, and in select patients with advanced disease, oxygen therapy, lung volume reduction surgery, or lung transplantation may also improve survival.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The accuracy of date of death recording in the C linical P ractice R esearch D atalink GOLD database in E ngland compared with the O ffice for N ational S tatistics death registrations

            Abstract Purpose It is not clear whether all deaths are recorded in the Clinical Practice Research Datalink (CPRD) or how accurate a recorded date of death is. Individual‐level linkage with national data from the Office for National Statistics (ONS) and Hospital Episode Statistics (HES) in England offers the opportunity to compare death information across different data sources. Methods Age‐standardised mortality rates (ASMRs) standardised to the European Standard Population (ESP) 2013 for CPRD were compared with figures published by the ONS, and crude mortality rates were calculated for a sample population with individual linkage between CPRD, ONS, and HES data. Agreement on the fact of death between CPRD and ONS was assessed and presented over time from 1998 to 2013. Results There were 33 997 patients with a record of death in the ONS data; 33 389 (98.2%) of these were also identified in CPRD. Exact agreement on the death date between CPRD and the ONS was 69.7% across the whole study period, increasing from 53.4% in 1998 to 78.0% in 2013. By 2013, 98.8% of deaths were in agreement within ±30 days. Conclusions For censoring follow‐up and calculating mortality rates, CPRD data are likely to be sufficient, as a delay in death recording of up to 1 month is unlikely to impact results significantly. Where the exact date of death or the cause is important, it may be advisable to include the individually linked death registration data from the ONS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.

              The leading comorbidities and causes of death in patients with chronic obstructive pulmonary disease (COPD) are lung cancer and cardiovascular disease. The aim of this study was to establish the incidence of lung cancer, myocardial infarction and heart failure in patients with COPD in UK primary care. The General Practice Research Database (GPRD) was used to identify a cohort of 1927 patients with a first recorded diagnosis of COPD. This cohort was followed for up to 5 years to identify new diagnoses of lung cancer, myocardial infarction and heart failure. Mortality was also assessed. The relative risk (RR) of each outcome in the COPD cohort was compared with that in a control cohort with no diagnosis of COPD. The risk of lung cancer was significantly increased in individuals with a diagnosis of COPD compared with those with no COPD diagnosis (RR: 3.33; 95% confidence interval [CI]: 2.33-4.75; adjusted for age, sex and smoking status). A diagnosis of COPD was also associated with a significant increase in the risk of heart failure (age- and sex-adjusted RR: 2.94; 95% CI: 2.46-3.51) and death (age- and sex-adjusted RR: 2.76; 95% CI: 2.45-3.12), but not myocardial infarction (age- and sex-adjusted RR: 1.18; 95% CI: 0.81-1.71). Patients with a diagnosis of COPD are at significantly increased risk of lung cancer, heart failure and death compared with the general population. They do not appear to be at increased risk of myocardial infarction. Copyright © 2010 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: SoftwareRole: ValidationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Data curation
                Role: MethodologyRole: Writing – review & editing
                Role: ConceptualizationRole: SupervisionRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                21 July 2020
                2020
                : 15
                : 7
                : e0236011
                Affiliations
                [1 ] MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
                [2 ] National Heart and Lung Institute, Imperial College London, London, United Kingdom
                National and Kapodistrian University of Athens, SWITZERLAND
                Author notes

                Competing Interests: Dr. Kiddle reports grants from Medical Research Council, during the conduct of the study; personal fees from Roche Diagnostics and DIADEM, outside the submitted work. After completing this work, but before manuscript submission Dr. Kiddle became an employee of AstraZeneca. Ms. Whittaker reports grants from GlaxoSmithKline, during the conduct of the study. Dr. Seaman has nothing to disclose. Dr. Quint reports grants from MRC, grants from The Health Foundation, grants from BLF, grants and personal fees from GSK, grants and personal fees from BI, grants and personal fees from Insmed, grants and personal fees from AZ, personal fees from Chiesi, personal fees from Teva, outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

                Author information
                http://orcid.org/0000-0003-4350-7437
                Article
                PONE-D-20-12164
                10.1371/journal.pone.0236011
                7373295
                32692772
                8c973bcf-96eb-4836-bc63-848d4f97b608
                © 2020 Kiddle et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 27 April 2020
                : 26 June 2020
                Page count
                Figures: 2, Tables: 5, Pages: 13
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MR/P021573/1
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MC_UU_00002/10
                Award Recipient :
                SJK is supported by a MRC Career Development Award (MR/P021573/1). SRS is supported by MRC Programme Grant (MC_UU_00002/10). The funders had no role in the decision to publish.
                Categories
                Research Article
                Medicine and Health Sciences
                Pulmonology
                Chronic Obstructive Pulmonary Disease
                Biology and Life Sciences
                Physiology
                Physiological Parameters
                Body Weight
                Body Mass Index
                Medicine and Health Sciences
                Physiology
                Physiological Parameters
                Body Weight
                Body Mass Index
                Medicine and Health Sciences
                Diagnostic Medicine
                Prognosis
                Research and Analysis Methods
                Mathematical and Statistical Techniques
                Statistical Methods
                Forecasting
                Physical Sciences
                Mathematics
                Statistics
                Statistical Methods
                Forecasting
                People and places
                Geographical locations
                Europe
                European Union
                United Kingdom
                England
                Biology and Life Sciences
                Biochemistry
                Proteins
                C-Reactive Proteins
                Medicine and Health Sciences
                Pulmonology
                Asthma
                Medicine and Health Sciences
                Cardiology
                Heart Failure
                Custom metadata
                The data used in our study originates from UK General Practice health records using the Vision software, and is provided in anonymised form by the Clinical Practice Research Datalink (CPRD, https://www.cprd.com/) to approved researchers for approved projects under strict conditions as assessed by their Independent Scientific Advisory Committee ( isac@ 123456cprd.com ) which holds broad ethics approval and is responsible for ensuring projects are covered by this. CPRD are the only entity legally allowed to share this data which although anonymised has the potential for reidentification in some cases. We attach our ISAC approved protocol and make our analysis scripts open source in order to help other researchers take the steps necessary to get approval from ISAC to reproduce our findings.

                Uncategorized
                Uncategorized

                Comments

                Comment on this article